Skip to main content

Improving Specificity of PSA Screening: Serum and Urine Markers - Who Doesn’t Need a Prostate Biopsy?

Daniel W. Lin, MD

University of Washington

Watch Now

 

Risk Stratifying Low-risk Disease: Molecular Markers

Marc Dall'Era, MD

UC Davis Comprehensive Cancer Care

Watch Now

 

mpMRI-guided Biopsy

Samir Taneja, MD

NYU Langone Medical Center

Watch Now

 

Focal Ablation of Prostate Cancer

Herbert Lepor, MD

NYU Langone Medical Center

Watch Now

 

Case Presentation with Panel Discussion

Hebert Lepor, MD

NYU Langone Medical Center

Watch Now

 

Advances in PET Imaging

Phillip J. Koo, MD

Banner MD Anderson Cancer Center

Watch Now

 

Understanding Hereditary Prostate Cancer: Evaluation and Management

Sanjeev Kaul, MD

Oakland University and William Beaumont Hospital

Watch Now

 

LHRH Antagonists vs Agonists

Lawrence Karsh, MD

The Urology Center of Colorado

Watch Now

 

Managing Bone Health in Advanced Prostate Cancer: What Every Urologist Should Know

David Quinn, MD, FACS

Keck School of Medicine of USC

Watch Now

 

Case Presentation with Panel Discussion

Herbert Lepor, MD

NYU Langone Medical Center

Watch Now

 

Advanced Prostate Cancer: Is There a Role for Urologists?

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now

 

Role of Immunotherapy in Advanced Prostate Cancer

David Quinn, MD

Keck School of Medicine of USC

Watch Now

 

Role of Androgen Receptor Blockers in Advanced Prostate Cancer

Evan Y. Yu, MD

University of Washington Medical Center

Watch Now

 

Role of PARPs and Other Novel Pathways

David Quinn, MD

Keck School of Medicine of USC

Watch Now

 

Role of Chemotherapy and Radiopharmaceuticals in the Management and Treatment of Advanced Prostate Cancer

Evan Y. Yu, MD

University of Washington Medical Center

Watch Now

 

Case Presentation with Panel Discussion

Neal D. Shore, MD, FACS

Carolina Urologic Research Center
Atlantic Urology Clinics

Watch Now